Researchers discover key functions of IRF1 in cancer progression and treatment response

FHS
July 16, 2024
3:08 am

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have uncovered new details about the role of a protein called interferon regulatory factor (IRF1) in cancer progression and treatment response, offering new insight that can potentially help improve the effectiveness of cancer immunotherapy.

Pot boss suspension: Goldberg-O’Brien meetings postponed due to, ‘unforeseen circumstances’ – The Cannabist

Related Articles The long-awaited meetings between suspended Cannabis Control Commission Chairwoman Shannon O’Brien and Treasurer Deborah Goldberg will not take place as scheduled Wednesday and

April 14, 2024

Canada’s plan to eliminate cervical cancer by 2040: HPV-based screening and vaccination key

The impact of three priority actions of the Canadian Partnership Against Cancer (CPAC) on the time to eliminate cervical cancer in British Columbia (BC), Canada.

June 5, 2024

Annual results as of 31.12.2022 and outlook 2023 – Biotech Investments

Vitruvia Medical AG / Key word(s): Annual Results/Annual Report Vitruvia Medical AG: Annual results as of 31.12.2022 and outlook 2023 25-Jun-2023 / 09:59 CET/CEST Disclosure

June 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.